Stay updated with breaking news from Markets Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) ("Merus", the "Company," "we" and "our"), a clinical-stage oncology company developing innovative
GTCR LLC entered into a definitive agreement to acquire Surmodics, Inc. for approximately $620 million on May 28, 2024. Under the terms of the agreement, affiliates of GTCR will acquire all...
BASE SHELF PROSPECTUS AND PRELIMINARY PROSPECTUS SUPPLEMENT ACCESSIBLE AND FINAL PROSPECTUS SUPPLEMENT TO BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ON SEDAR+ VANCOUVER, British Columbia, May 28, 2024 ...
BASE SHELF PROSPECTUS AND PRELIMINARY PROSPECTUS SUPPLEMENT ACCESSIBLE AND FINAL PROSPECTUS SUPPLEMENT TO BE ACCESSIBLE WITHIN TWO BUSINESS DAYS ON SEDAR+ VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) --
UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 28, 2024 -- Merus N.V. , a clinical-stage oncology company developing innovative, full-length multispecific antibodies , today announced the...